Literature DB >> 23814348

Validation of the Multiple Suggested Immobilization Test: A Test for the Assessment of Severity of Restless Legs Syndrome (Willis-Ekbom Disease).

Diego Garcia-Borreguero1, Ralf Kohnen, Lindsay Boothby, Desislava Tzonova, Oscar Larrosa, Elmar Dunkl.   

Abstract

STUDY
OBJECTIVES: To validate the Multiple Suggested Immobilization Test (m-SIT), a symptom-provocation test measuring restless legs syndrome (RLS) severity multiple times a day while the patient is awake and resting under controlled conditions. The m-SIT was designed to overcome some limitations in measuring RLS severity with rating scales.
DESIGN: Patients completed two m-SITs on 2 consecutive days while on 24-h dopaminergic medication. After treatment discontinuation, they completed one more m-SIT 3 days later. Controls performed only one m-SIT.
SETTING: Sleep laboratory. PARTICIPANTS: Nineteen patients with RLS and 10 healthy controls.
INTERVENTIONS: The original m-SIT consisted of seven modified 60-min SITs performed every 2 h between noon and midnight. During each SIT, the subject reclined quietly but could move his or her legs without restriction to alleviate symptoms. Every 10 min, periodic leg movements during wakefulness (PLMW) were evaluated and the m-SIT Disturbance Scale (m-SIT-DS; range 0-10) was completed. MEASUREMENTS AND
RESULTS: The m-SIT, composed of 6:00pm, 8:00pm, 10:00pm, and 12:00pm SITs, discriminated patients from controls (mean m-SIT-DS: 2.68 ± 2.35 versus 0.08 ± 0.26; mean PLMW/h, P = 0.0001) and between treatment groups (on medication versus taken off medication; mean m-SIT-DS, P = 0.0001; mean PLMW/h, P < 0.01). It proved reliable on retest and covariated well with the International Restless Legs Scale (IRLS) and scales measuring daytime symptoms (Spearman ρ > 0.4).
CONCLUSIONS: The m-SIT is a valid and reliable test to evaluate RLS severity and treatment response, and could be useful in the future to confirm diagnosis and identify daytime symptoms. Although it was primarily designed for clinical trials, it might be useful in clinical settings because it provides a standardized testing condition to measure RLS symptoms. CITATION: Garcia-Borreguero D; Kohnen R; Boothby L; Tzonova D; Larrosa O; Dunkl E. Validation of the Multiple Suggested Immobilization Test: a test for the assessment of severity of restless legs syndrome (Willis-Ekbom disease). SLEEP 2013;36(7):1101-1109.

Entities:  

Keywords:  Daytime symptoms; Willis-Ekbom disease; laboratory tests; restless legs syndrome

Year:  2013        PMID: 23814348      PMCID: PMC3669063          DOI: 10.5665/sleep.2820

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  27 in total

1.  Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study.

Authors:  Wayne Hening; Arthur S Walters; Richard P Allen; Jacques Montplaisir; Andrew Myers; Luigi Ferini-Strambi
Journal:  Sleep Med       Date:  2004-05       Impact factor: 3.492

2.  The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG).

Authors:  Marco Zucconi; Raffaele Ferri; Richard Allen; Paul Christian Baier; Oliviero Bruni; Sudhansu Chokroverty; Luigi Ferini-Strambi; Stephany Fulda; Diego Garcia-Borreguero; Wayne A Hening; Max Hirshkowitz; Birgit Högl; Magdolna Hornyak; Martin King; Pasquale Montagna; Liborio Parrino; Giuseppe Plazzi; Mario G Terzano
Journal:  Sleep Med       Date:  2006-02-03       Impact factor: 3.492

3.  PLM detection by actigraphy compared to polysomnography: a validation and comparison of two actigraphs.

Authors:  Viola Gschliesser; Birgit Frauscher; Elisabeth Brandauer; Ralf Kohnen; Hanno Ulmer; Werner Poewe; Birgit Högl
Journal:  Sleep Med       Date:  2008-07-24       Impact factor: 3.492

4.  Effects of rest-duration, time-of-day and their interaction on periodic leg movements while awake in restless legs syndrome.

Authors:  Richard P Allen; Terry Dean; Christopher J Earley
Journal:  Sleep Med       Date:  2005-09       Impact factor: 3.492

Review 5.  Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

Authors:  Richard P Allen; Daniel Picchietti; Wayne A Hening; Claudia Trenkwalder; Arthur S Walters; Jacques Montplaisi
Journal:  Sleep Med       Date:  2003-03       Impact factor: 3.492

6.  Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome.

Authors:  Richard Allen; Philip M Becker; Richard Bogan; Markus Schmidt; Clete A Kushida; June M Fry; J Steven Poceta; David Winslow
Journal:  Sleep       Date:  2004-08-01       Impact factor: 5.849

Review 7.  Assessment of restless legs syndrome--methodological approaches for use in practice and clinical trials.

Authors:  Ralf Kohnen; Richard P Allen; Heike Benes; Diego Garcia-Borreguero; Wayne A Hening; Karin Stiasny-Kolster; Marco Zucconi
Journal:  Mov Disord       Date:  2007       Impact factor: 10.338

Review 8.  Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.

Authors:  Stephany Fulda; Thomas C Wetter
Journal:  Brain       Date:  2007-10-11       Impact factor: 13.501

9.  Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome.

Authors:  Diego García-Borreguero; Ralf Kohnen; Birgit Högl; Luigi Ferini-Strambi; Georgios M Hadjigeorgiou; Magdolna Hornyak; Al W de Weerd; Svenja Happe; Karin Stiasny-Kolster; Viola Gschliesser; Renata Egatz; Belen Cabrero; Birgit Frauscher; Claudia Trenkwalder; Wayne A Hening; Richard P Allen
Journal:  Sleep Med       Date:  2007-05-31       Impact factor: 3.492

Review 10.  Restless legs syndrome and periodic limb movements during sleep: diagnosis and treatment.

Authors:  Mehmet Karatas
Journal:  Neurologist       Date:  2007-09       Impact factor: 1.398

View more
  10 in total

1.  The effect of vitamin D supplements on the severity of restless legs syndrome.

Authors:  Siraj Wali; Afnan Shukr; Ayah Boudal; Ahmad Alsaiari; Ayman Krayem
Journal:  Sleep Breath       Date:  2014-08-23       Impact factor: 2.816

2.  F-Wave Duration as a Specific and Sensitive Tool for the Diagnosis of Restless Legs Syndrome/Willis-Ekbom Disease.

Authors:  Patrizia Congiu; Maria Livia Fantini; Giulia Milioli; Paolo Tacconi; Michela Figorilli; Gioia Gioi; Bruno Pereira; Francesco Marrosu; Liborio Parrino; Monica Puligheddu
Journal:  J Clin Sleep Med       Date:  2017-03-15       Impact factor: 4.062

3.  Prevalence and Characteristics of Periodic Limb Movements during Sleep in Korean Adult Patients with Restless Legs Syndrome.

Authors:  Jung-Won Shin; Yong Seo Koo; Byeong Uk Lee; Won Chul Shin; Sang Kun Lee; Yong Won Cho; Ki-Young Jung
Journal:  J Clin Sleep Med       Date:  2016-08-15       Impact factor: 4.062

Review 4.  Update on Restless Legs Syndrome: from Mechanisms to Treatment.

Authors:  Paulina Gonzalez-Latapi; Roneil Malkani
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-27       Impact factor: 5.081

5.  Noninvasive neuromodulation reduces symptoms of restless legs syndrome.

Authors:  Mark J Buchfuhrer; Fiona C Baker; Haramandeep Singh; Viktoriia Kolotovska; Bahman Adlou; Harnadar Anand; Massimiliano de Zambotti; Mehvish Ismail; Shriram Raghunathan; Jonathan D Charlesworth
Journal:  J Clin Sleep Med       Date:  2021-08-01       Impact factor: 4.324

6.  Clinical Practice Guideline on Management of Sleep Disorders in the Elderly.

Authors:  Samir Kumar Praharaj; Ravi Gupta; Navendu Gaur
Journal:  Indian J Psychiatry       Date:  2018-02       Impact factor: 1.759

Review 7.  Restless legs syndrome: Over 50 years of European contribution.

Authors:  Samson G Khachatryan; Raffaele Ferri; Stephany Fulda; Diego Garcia-Borreguero; Mauro Manconi; Maria-Lucia Muntean; Ambra Stefani
Journal:  J Sleep Res       Date:  2022-07-09       Impact factor: 5.296

8.  Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosis.

Authors:  Katie L J Cederberg; Arthur S Walters; Amy W Amara; Tiffany J Braley; Morgan L Schuetz; Brianna G Mathison; Robert W Motl
Journal:  Sleep Med       Date:  2021-06-16       Impact factor: 4.842

9.  "Emplotted Narratives" and Structured "Behavioral Observations" Supporting the Diagnosis of Willis-Ekbom Disease/Restless Legs Syndrome in Children with Neurodevelopmental Conditions.

Authors:  Osman S Ipsiroglu; Nadia Beyzaei; Mai Berger; Alexandra L Wagner; Sophia Dhalla; Jennifer Garden; Sylvia Stockler
Journal:  CNS Neurosci Ther       Date:  2016-06-13       Impact factor: 5.243

10.  A Randomized, Placebo-Controlled Crossover Study with Dipyridamole for Restless Legs Syndrome.

Authors:  Diego Garcia-Borreguero; Celia Garcia-Malo; Juan José Granizo; Sergi Ferré
Journal:  Mov Disord       Date:  2021-06-17       Impact factor: 9.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.